Cargando…
Rationally combining anti-VEGF therapy with radiation in NF2 schwannoma
Neurofibromatosis type 2 is characterized by bilateral vestibular schwannomas, which are benign tumors that originate from the nerve sheath and damage the nerve as they grow, causing neurological dysfunction such as hearing loss. Current standard radiation therapy can further augment hearing loss by...
Autores principales: | Zhang, Na, Gao, Xing, Zhao, Yingchao, Datta, Meenal, Liu, Pinan, Xu, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300073/ https://www.ncbi.nlm.nih.gov/pubmed/28191549 |
Ejemplares similares
-
Anti-VEGF therapy improves EGFR-vIII-CAR-T cell delivery and efficacy in syngeneic glioblastoma models in mice
por: Dong, Xinyue, et al.
Publicado: (2023) -
Therapy of Sporadic and NF2-Related Vestibular Schwannoma
por: Yao, Longping, et al.
Publicado: (2020) -
Vestibular Schwannoma: Results of Hypofractionated Stereotactic Radiation Therapy
por: Pialat, Pierre-Marie, et al.
Publicado: (2021) -
Vestibulocochlear Delineation for Vestibular Schwannoma Treated With Radiation Therapy
por: Restini, Felipe Cicci Farinha, et al.
Publicado: (2023) -
The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy
por: Pożarowska, Dorota, et al.
Publicado: (2016)